Trials / Completed
CompletedNCT05354713
NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)
An Clinical Trial to Evaluate the Pharmacokinetics and the Safety of NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2
Detailed description
Evaluate pharmacokinetics and safety of NVP-1805 compared to coadministration of NVP-1805-R1 with NVP-1805-R2
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-1805 | NVP-1805 (80/10/20.8mg) |
| DRUG | NVP-1805-R1 and NVP-1805-R2 | coadministration of NVP-1805-R1(80mg) and NVP-1805-R2(10/20.8mg) |
Timeline
- Start date
- 2022-11-05
- Primary completion
- 2023-03-20
- Completion
- 2023-04-27
- First posted
- 2022-04-29
- Last updated
- 2023-05-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05354713. Inclusion in this directory is not an endorsement.